Background: A positive association between elevated circulating YKL-40 levels and increasing levels of albuminuria have been described in patients with type 1 diabetes indicating a role of YKL-40 in the progressing vascular damage resulting in microvascular disease. Aim of study: Was to evaluate serum YKL-40 level and its association with albuminuria in Egyptian type 1 diabetic patients. Subjects and Methods: Study was carried out on 50 patients from those attending diabetes clinics of Banha University Hospital they were divided into two groups: Group (a): Includes 20 healthy individuals their ages ranged from 20-35 years (12 males and 8 females), they were clinically free with normal laboratory findings. Group (b): Includes 30 diabetic patients (18 males and 12 females), their ages ranged from 30-48 years with type 1 DM and microalbuminuria. The following laboratory investigations were performed to all patients: Fasting plasma glucose, HbA1c, serum lipid profile, serum creatinine, estimated glomerular filtration rate, urinary albumin / creatinine ratio (ACR), serum YKL-4. Results: Our results show: Statistically significant increase in the mean of fasting blood sugar (FPG), hemoglobin A1c (HbA1c) , microalbumin in urine, ACR levels in diabetic group compared to control group. Significant increase in the mean of low density lipoprotein cholesterol (LDL-C), triglycerides, serum creatinine, urinary creatinine and YKL-40 levels in diabetic group compared to control group. The mean of high density lipoprotein cholesterol l (HDL-C) and estimated glomeular filtration rate (eGFR) levels show a highly statistically significant decrease in diabetic group compared to control group. A significant positive correlation between ACR and each of age and duration of diabetes. Significant positive correlation between ACR and each of FPG , HbA1c, triglycerides, serum creatinine and microalbumin in urine and negative correlation with eGFR. Significant positive correlation between YKL-40 and each of age and duration of diabetes. Significant positive correlation between YKL-40 and each of FPG, HbA1C, HDL, triglycerides, serum creatinine, microalbumin in urine, urinary creatinine and ACR, and negative correlation with eGFR. No significant difference of sex distribution among the studied groups. Insignificant difference in the mean of (diastolic and systolic blood pressure, total cholesterol level in diabetic group compared to control group). No significant correlation was found between ACR and systolic or diastolic blood pressure. No significant correlation between ACR and each of total cholesterol, LDL-C, HDL-C and urinary creatinine. No significant correlation betweenYKL-40 and systolic or diastolic blood pressure. No significant correlation between YKL-40 and each of total cholesterol and LDL-C. Conclusion: It was concluded that Egyptian type1 diabetic patients serum YKL-40 levels are significantly elevated and have a linear association with albuminuria. These data suggest that YKL-40 levels could be a tool to assess the risk of diabetic microangiopathy in early stage of type1 diabetes.
Introduction
Diabetes Mellitus is commonly associated with both microvascular and macrovascular complications and associated with multiple disorders including metabolic, cellular and blood coagulation disturbances leading to many complications affecting various organs such as kidney , retina , peripheral nerves, microvascular and macrovascular compartments 1 .
About 246 million people worldwide had diabetes in 2007. The global figure of people with diabetes is projected to increase to 370 million in 2030. As the prevalence of diabetes has risen to epidemic proportions worldwide, diabetic nephropathy has become one of the most challenging health problems 2 .
Diabetic nephropathy is a major microvascular complication & the leading cause of end-stage renal disease worldwide. Under hyperglycemic condition, it has been demonstrated that the renal tubular epithelium highly expresses apoptosis regulatory genes 3 .
YKL-40 is a 40 kDa heparin-and chitin-binding glycoprotein also known as human cartilage glycoprotein 39 (HC-gp39), 38-kDa heparin-binding glycoprotein or chitinase-3-like protein 1 (CHI3L1) 4 .
YKL-40 is an inflammatory glycoprotein involved in endothelial dysfunction by promoting chemotaxis, cell attachment, migration, reorganization and tissue remodelling as a response to endothelial damage. YKL-40 protein expression is seen in macrophages and smooth muscle cells in atherosclerotic plaques with the highest expression seen in macrophages in the early lesion of atherosclerosis. YKL-40 levels are elevated both in patients with type 1 and type 2 diabetes, known to be at high risk for the development of cardiovascular diseases when compared to nondiabetic persons. A positive association between elevated circulating YKL-40 levels and increasing levels of albuminuria have been described in patients with type 1 diabetes indicating a role of YKL-40 in the progressing vascular damage resulting in microvascular disease 5 .
Subjects and Methods
The present study was conducted at internal medicine and clinical pathology departments of Banha University Hospitals. It was carried out on 50 subjects during the period from April 2014 to April 2015. They were classified into two groups:
Group (a) control group: It included 20 apparently healthy individuals (12 males and 8 females), their ages ranged from 20-35 years. They were clinically free with normal laboratory findings.
Group (b) diabetic group (Cases):
It included 30 patients (18 males and 12 females), their ages ranged from 30-48 years with type 1 DM (T1DM) and microalbuminuria (defined by spot morning albumin /creatinine ratio ≥ 30 mg/g).
Inclusion criteria: All patients were type 1 DM according to the criteria for diagnosis of diabetes (ADA, 2008) : HbA1c ≥ 6.5%, or FPG ≥ 126 mg/dl (7mmol/l)or 2-h plasma glucose ≥ 200 mg/dl (11.1mmol/l). In a patient with classic symptoms of hyperglycemia or hyperglycemic crisis, a random plasma glucose ≥ 200 mg/dl (11.1 mmol/l). Urinary albumin / creatinine ratio, serum YKL-40.
Sampling:
1) The Blood samples were obtained by peripheral venipuncture from all subjects, after at least 10 hours fast were divided into two parts:
The first part (1 ml) was collected on EDTA tubes for fasting plasma glucose and HbA1c. The second part (4 ml) was collected in sterile tubes then put in water path at 37 C for 30 minutes then centrifuged for 10 minutes then the resultant serum was divided into aliquots and stored at -20 C for measurement of serum lipid profile, serum creatinine, serum YKL-40. Frozen samples were allowed to thaw and brought to room temperature only before analysis. Hemolysed samples were discarded, repeated freezing and thawing was avoided.
2) A single early morning urine sample was obtained in aclean sterile cup for estimation of albumin /creatinine ratio.
Methods:

Estimation of urinary microalbumin:
Principle of the method: 7, 8, 9, 10 Albumin in the urine sample causes agglutination of the latex particles with anti -human albumin. The agglutination of the particles is proportional to the albumin concentration and can be measured by turbidimetry.
Reference values:
11 Urine, adults: Up to 15 mg/L.
All previous tests were done on Automated chemistry analyzer Biosystem A15.
Calculation of the albumin/creatinine ratio in mg/g.
If the urine microalbumin is 10 mg/L and the urine creatinine is 100 mg/dL, then the albumin/creatinine ratio is 10 mg/g. In this example, you first need to multiply the urine creatinine value by 10 in order to convert mg/L (i.e., 100 mg/dL × 10 dL/ L= 1000 mg/L). Then simply divide the urine albumin value (10 mg/L ) by the urine creatinine value (1000 mg/L) to arrive at the ratio (10 mg/L /1000 mg/L=0.01), then multiply by 1000 to express the value as (mg albumin /g creatinine). If the two values are already in the same units, simply divide the albumin value by the creatinine value and then multiply by 1000 12 . Normal value of ACR is < 30 mg/g, microalbuminuria ACR is 30-300 mg/g, and macroalbuminuria ACR is >300 mg/g 13 .
Assay of human (YKL-40 / CHI3L1)
Test principle :
11
The kit uses a double -antibody sandwich enzymelinked immunosorbent assay (ElISA) to assay the level of Chitinase-3-like protein 1 (YKL-40/CHI3L1) in samples and it is supplied by SunRed company. Chitinase-3-like protein 1 (YKL-40/CHI3L1) was added to monoclonal antibody enzyme well which is pre-coated with Human Chitinase-ion3-like protein 1 (YKL-40/CHI3L1) monoclonal antibody, incubation then, (YKL-40/CHI3L1) antibodies labeled with biotin were added, and combined with streptavidin -HRP to form immune-complex; then incubation and washing were carried out again to remove the uncombined enzyme. Then chromogen solution A,B were added the color of the liquid changes into the blue, and at the effect of acid, the color finally becomes yellow. The chroma of color and the concentration of the human substance Chitinase-3-like protein 1 (YKL-40/CHI3L1) of sample were positively correlated.
Statistical analysis
The results were analyzed using SPSS ( 
Results
The present study comprised of 30 type 1 diabetic patients (18 males &12 females) and 20 apparently healthy subjects serving as a control group (12 males and 8 females). The results were presented in 6 tables. Shows a statistically significant increase in the mean of FPG, HbA1c, microalbumin in urine, ACR levels in diabetic group compared to control group (P < 0.01).
There was a statistically significant increase in the mean of LDL-C, triglycerides, S.creatinine, urinary creatinine and YKL-40 (P < 0.05) levels in diabetic group compared to control group. While the mean of HDL-C and eGFR levels shows a highly statistically significant decrease in diabetic group compared to control group (P < 0.01). No statistically significant difference was detected in the mean of total cholesterol (P ˃ 0.5) levels in diabetic group compared to control group. Table ( 3) Shows a significant positive correlation between ACR and each of age and duration of diabetes 20 . The aim of the present study is to evaluate serum YKL-40 levels and its association with albuminuria in Egyptian type 1 diabetic patients.
The study was conducted at internal medicine and clinical pathology departments of Banha University Hospitals. It was carried out on 50 subjects (30 type 1 diabetic patients and 20 apparently healthy individuals working as control group) during the period from April 2014 to April 2015. All the procedures used in this study were approved by the medical ethics committee of the faculty of medicine, Banha University, Egypt. An informed consent was obtained from all subjects in this study. The results of the present work showed no significant difference of sex distribution among the studied groups. The results of the present work showed insignificant difference in the mean of diastolic blood pressure and systolic blood pressure levels in diabetic group compared to control group. These results were in concordance with Graziella et al. 21 and Sakamoto et al. 22 which reported that there was no significant difference between the diabetic and control groups in systolic and diastolic blood pressure while Rathcke et al. 5 reported that there was no significant difference in systolic blood pressure between the diabetic group and control groups but there is a significant difference in diastolic blood pressure between diabetic group and control group. The results of the present study showed a statistically significant increase in the mean of FPG and HbA1c in diabetic group compared to control group. The increase in FPG and HbA1c in diabetic patients than control group were in concordance with many studies 23,24,25,26 . In diabetic patients glucose reacts with amino groups on proteins to form covalently bonded glycated products. An example of such product is glycated hemoglobin used to monitor the long term control of glucose in diabetic patients. A decrease in HDL-C in diabetic patients has often been reported in combination with altered composition of HDL-C 32 . Similar to VLDL and LDL, HDL particles contain an increased proportion of triglycerides. Triglycerides-rich HDL shows a faster catabolic rate than normal HDL, followed by a decreased number of circulating HDL particles 37 .
This is in concordance with
The results of the present work showed that eGFR shows a high statistically significant decrease in diabetic group compared to control group. The decrease in eGFR in diabetic patients than control group is in concordance with Schram 38 , Astrup 39 .
In diabetic patients, nephropathy and hyperlipidemia has been identified as risk factors for more rapid rate of decline in eGFR and mortality. An increased plasma concentration of triglycerides rich apoB containing lipoproteins has been found to be linked to a more rapid decrease in renal function 40 .
However Alvin and Powers 41 stated that glomerular hyperperfusion and renal hypertrophy occur in the first years after the onset of DM and are reflected by an increased glomerular filtration rate. Before the onset of overt proteinuria, there are various renal functional changes including renal hyperfiltration, hyperperfusion, and increasing capillary permeability to macro-molecules 42 .
The results of the present work showed a statistically significant increase S.creatinine, urinary creatinine, microalbumin in urine, ACR levels in diabetic group compared to control group.
The significant increase noted in creatinine level in diabetic patients than control group was in concordance with UK Prospective Diabetes Study Group 43 , Chaturvedi and his colleagues 44 and Gross et al. 45 who found significant increase of creatinine level in all diabetic patients, as the progression of diabetic nephropathy starts in early course of diabetes.
De-Zeeuw et al.
46 suggested that ACR should be considered a risk marker for progressive loss of renal function. Also they reported that, albuminuria is the predominant renal risk marker in diabetic patients with nephropathy; the higher the albuminuria, the greater the renal risk.
Proteinuria directly contributes to its pathogenesis by including tubulointerstitial pathology. Itself a major correlate of declining in renal function. Other mechanisms such as the enhanced ultrafilteration of growth factors may also contribute 47 .
The progression from microalbuminuria to macroalbuminuria (overt nephropathy) is associated with several risk factors including: elevation of urinary albumin excretion, poor glycemic control, genetic factors, long duration of diabetes, abnormalities in lipid spectrum and haemostatic parameters 48 .
Like other microvascular complications, the pathogenesis of diabetic nephropathy is related to chronic hyperglycemia. There are three major theories, which explain how hyperglycemia might lead to diabetic nephropathy. One hypothesis is that increased intracellular glucose leads to the formation of advanced glycosylation end products (AGEs) via the nonenzymatic glycosylation of cellular proteins. A second hypothesis is that hyperglycemia increases glucose metabolism via the sorbitol pathway and this leads to cellular dysfunction. A third hypothesis proposes that hyperglycemia increases the formation of diacylglycerol leading to activation of certain isoforms of protein kinase C (PKC), which, in turn, affect a variety of cellular events that lead to DMrelated complications. Also growth factors appear to play an important role in DM-related complications
49.
The results of the present work showed a significant positive correlation between ACR and each of age and duration of diabetes and no significant correlation between ACR and systolic blood pressureand diastolic blood pressure.
(Brenner et al. 50 , Alder et al. 51 and Molitch et al. 52 suggested that there is a constant deterioration of renal function of the diabetic patients over time or progression of nephropathy over time.
Khan et al.
53 suggest a link between development and progression of diabetic nephropathy and duration of diabetes.
The results of the present work showed a significant positive correlation between ACR and each of FPG, HbA1c, triglycerides, S.creatinineand microalbumin in urine.
Diabetic dyslipidemia plays a major role in the pathophysiology and progression of vascular disease and probably diabetic nephropathy as well 50 . The increased plasma concentration of triglycerides rich Apo-B containing lipoproteins with low levels of HDL-C have been found to be linked to a more rapid decrease in renal function and development of diabetic nephropathy 54,55 .
The results of the present work showed a statistically significant increase in YKL-40 level in diabetic group compared to control group. Also, there was a significant positive correlation between YKL-40 and each of age and duration of diabetesandno significant correlation betweenYKL-40 and systolic blood pressure and diastolic blood pressure.
These findings are in concordance with three previous studies performed in type 1 DM. Rathcke et al.
5
reported elevated YKL-40 levels in a cohort of Danish, middle aged (50 years) T1D patients, with a long diabetes duration (30 years) and with high prevalence of microvascular complications (more than 50%) and Sakamoto et al. 22 showed also elevated levels of YKL-40 in a cohort of Japanese T1D patients younger than the cohort of Danish patients (mean age of 25 years), with less mean duration of diabetes (13 years) and with a lower prevalence of microvascular complications (9% of microalbuminuria, 33% of retinopathy) and Aguilera et al. 56 who reported a mean age and duration of diabetes intermediate between the above two studies, but with a much lower prevalence of microangiopathy than the Danish cohort and similar to the Japanese patients.
Astrup et al.
39 andSchram et al. 38 explained the increase of YKL-40 (chitinase 3-like protein 1) in diabetic patients by being a marker of inflammation and endothelial dysfunction, both of which play important roles in the progression of diabetic complications. It has a role in inflammation and remodeling of extracellular matrix. Clinical studies showed that biomarkers of inflammation and endothelial dysfunction were higher in type 1 diabetic patients with diabetic complications.
The results of the present work showed a significant positive correlation between YKL-40 and each of FPG, HbA1C, HDL-C, triglycerides, serum creatinine, microalbumin in urine, urinary creatinine and ACR and negative correlation with eGFR. On the other hand there is no significant correlation between YKL-40 and each of total cholesterol and LDL.
These results were in concordance with Rathcke et al.
5
and Sakamoto et al. 22 who described elevated concentrations of YKL-40 in T1D patients with microalbuminuria but against is Aguilera et al.
56
reporting that YKL-40 is already increased even at a stage when subclinical microvascular and macrovascular disease is not detected with current clinical procedures or if it is modestly present. The low proportion of T1D patients presenting nephropathy (9%) but showing high YKL-40 compared to controls clearly indicates that at this stage of T1D evolution, inflammatory status is already activated. Moreover, they did not find higher levels of YKL-40 in nephropathy patients at the stage of positive microalbuminuria, and although they did not find differences according to the presence or absence of retinopathy, probably due to the low number of subjects included in their cohort, all the data taken together suggest that more prospective studies are probably needed in order to clarify if relevant changes in the magnitude of YKL-40 concentration are detected over time and in relation to the appearance of microvascular disease.
Schram et al.
38 , Lin et al. 57 and Klein et al. 58 showed that the chronic low grade inflammation and endothelial dysfunction were associated with the occurrence and progression of diabetic microangiopathy including nephropathy and retinopathy. Thus, it is possible that YKL-40 plays an important role in the pathogenesis of diabetic microangiopathy via intermediating low grade inflammation and endothelial dysfunction.
Gerstein et al.
59 , Rossing et al. 60 ,Johansen 61 and Molitch et al. 62 showed that the presence of albuminuria and decline of estimated GFR are not only a predictor of progression of nephropathy in type 1 diabetic patients, but also a risk factor for cardiovascular disease with or without diabetes mellitus. Inflammation and endothelial dysfunction are thought to be key processes in the progression of atherosclerosis.
YKL-40 modulates vascular endothelial cell morphology by promoting the formation of branching tubule, indicating that YKL-40 may function in angiogenesis by stimulating the migration and reorganization of vascular endothelial cells.
Conclusion
In conclusion, serum YKL-40 levels were elevated in type 1 diabetic patients and associated with increasing level of albuminuria. YKL-40 could be a predictor to assess the risk of diabetic microangiopathy in the early stage in type 1 diabetic patients. 
